Should magnesium be given to every migraineur? No

Journal of Neural Transmission

Volumn 119, Issue 5, 2012, Pages 581-585

  Pardutz, Arpad ^a   Vecsei, Laszlo ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Magnesium; Migraine; Treatment

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANALGESIC AGENT; MAGNESIUM ION; MAGNESIUM SULFATE; METOCLOPRAMIDE; PLACEBO; PYRROLIDONE CARBOXYLATE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBOFLAVIN; TETRACYCLINE; TRIMAGNESIUM DICITRATE; UNCLASSIFIED DRUG;

DIARRHEA; DRUG EFFICACY; DRUG SAFETY; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; MAGNESIUM BLOOD LEVEL; MIGRAINE; MUSCLE WEAKNESS; NAUSEA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY FAILURE; REVIEW; SIDE EFFECT; TANACETUM PARTHENIUM; THIRST; TREATMENT CONTRAINDICATION; VOMITING;

ANALGESICS; HUMANS; MAGNESIUM; MAGNESIUM DEFICIENCY; MIGRAINE DISORDERS;

EID: 84863501284     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0791-1     Document Type: Review

References (50)

1. Andersson KE, Vinge E (1990) Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine. Drugs 39:355-373
2. Banai S, Tzivoni D (1993) Drug therapy for torsade de pointes. J Cardiovasc Electrophysiol 4:206-210
3. Barbiroli B, Montagna P, Cortelli P, Martinelli P, Sacquegna T, Zaniol P, Lugaresi E (1990) Complicated migraine studied by phosphorus magnetic resonance spectroscopy. Cephalalgia 10: 263-272
4. Barbiroli B, Montagna P, Cortelli P, Funicello R, Iotti S, Monari L, Pierangeli G, Zaniol P, Lugaresi E (1992) Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology 42:1209-1214
5. Bigal ME, Bordini CA, Tepper SJ, Speciali JG (2002) Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia 22:345-353
6. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA (2002) Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8:136-142
7. Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964-982
8. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH (2000) An association between migraine and cutaneous allodynia. Ann Neurol 47:614-624
9. Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C (2005) A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department. Cephalalgia 25:199-204
10. Ciarkowski SL, Stalburg CM (2010) Medication safety in obstetrics and gynecology. Clin Obstet Gynecol 53:482-499
11. Corbo J, Esses D, Bijur PE, Iannaccone R, Gallagher EJ (2001) Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Ann Emerg Med 38:621-627
12. Demirkaya S, Vural O, Dora B, Topcuoglu MA (2001) Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache 41:171-177
13. Diener HC (1997) Positron emission tomography studies in headache. Headache 37:622-625
14. Ebel H, Gunther T (1980) Magnesium metabolism: a review. J Clin Chem Clin Biochem 18:257-270
15. Elin RJ (1994) Magnesium: the fifth but forgotten electrolyte. Am J Clin Pathol 102:616-622
16. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sandor PS (2009) EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. Eur J Neurol 16:968-981
17. Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G (1991) Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 31:298-301
18. Gallai V, Sarchielli P, Morucci P, Abbritti G (1993) Red blood cell magnesium levels in migraine patients. Cephalalgia 13:81-94
19. Goadsby PJ, Edvinsson L, Ekman R (1988) Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 23:193-196
20. Grubbs RD, Maguire ME (1987) Magnesium as a regulatory cation: criteria and evaluation. Magnesium 6:113-127
21. Guerrera MP, Volpe SL, Mao JJ (2009) Therapeutic uses of magnesium. Am Fam Physician 80:157-162
22. Jackson JL, Shimeall W, Sessums L, Dezee KJ, Becher D, Diemer M, Berbano E, O'Malley PG (2010) Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ 341:c5222
23. Koseoglu E, Talaslioglu A, Gonul AS, Kula M (2008) The effects of magnesium prophylaxis in migraine without aura. Magnes Res 21:101-108
24. Lance JW, Lambert GA, Goadsby PJ, Duckworth JW (1983) Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine. Headache 23:258-265
25. Lauritzen M (1994) Pathophysiology of the migraine aura. The spreading depression theory. Brain 117:199-210
26. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41:646-657
27. Maizels M, Blumenfeld A, Burchette R (2004) A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial. Headache 44:885-890
28. Mathew PJ, Muthurajan N, Wig J (2010) Progressive muscle weakness with respiratory insufficiency in a young patient with tetanus during magnesium sulfate infusion. Acta Anaesthesiol Taiwan 48:152-154
29. Mauskop A, Altura BT, Cracco RQ, Altura BM (1993) Deficiency in serum ionized magnesium but not total magnesium in patients with migraines. Possible role of ICa2+/IMg2+ ratio. Headache 33:135-138
30. Mayer ML, Westbrook GL, Guthrie PB (1984) Voltage-dependent block by Mg2? of NMDA responses in spinal cord neurones. Nature 309:261-263
31. Moskowitz MA, Nozaki K, Kraig RP (1993) Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 13:1167-1177
32. Onalan O, Crystal E, Daoulah A, Lau C, Crystal A, Lashevsky I (2007) Meta-analysis of magnesium therapy for the acute management of rapid atrial fibrillation. Am J Cardiol 99:1726-1732
33. Peikert A, Wilimzig C, Kohne-Volland R (1996) Prophylaxis of migraine with oral magnesium: results from a prospective, multicenter, placebo-controlled and double-blind randomized study. Cephalalgia 16:257-263
34. Pfaffenrath V, Wessely P, Meyer C, Isler HR, Evers S, Grotemeyer KH, Taneri Z, Soyka D, Gobel H, Fischer M (1996) Magnesium in the prophylaxis of migraine-a double-blind placebo-controlled study. Cephalalgia 16:436-440
35. Ramadan NM, Halvorson H, Vande-Linde A, Levine SR, Helpern JA, Welch KM (1989) Low brain magnesium in migraine. Headache 29:416-419
36. Rothrock JF (1997) Clinical studies of valproate for migraine prophylaxis. Cephalalgia 17:81-83
37. Rude RK, Shils ME (2006) Magnesium. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ (eds) Modern Nutrition in Health and Disease, 10th edn. Lippincott Williams & Wilkins, Baltimore, pp 223-248
38. Sandor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J (2005) Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 64:713-715
39. Schoenen J, Jacquy J, Lenaerts M (1998) Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 50:466-470
40. SmeetsMC,Vernooy CB, Souverijn JH, FerrariMD(1994) Intracellular and plasma magnesium in familial hemiplegic migraine and migraine with and without aura. Cephalalgia 14:29-32
41. Strassman AM, Raymond SA, Burstein R (1996) Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384:560-564
42. Taubert K (1994) Magnesium in migraine. Results of a multicenter pilot study. Fortschr Med 112:328-330
43. Trauninger A, Pfund Z, Koszegi T, Czopf J (2002) Oral magnesium load test in patients with migraine. Headache 42:114-119
44. Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ (2003) Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 43:601-610
45. Weiller C, May A, Limmroth V, Juptner M, Kaube H, Schayck RV, Coenen HH, Diener HC (1995) Brain stem activation in spontaneous human migraine attacks. Nat Med 1:658-660
46. Welch KM, Levine SR, D'Andrea G, Schultz LR, Helpern JA (1989) Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology 39:538-541
47. Welch KM, Nagesh V, Aurora SK, Gelman N (2001) Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41:629-637
48. Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL (1997) Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia 17:518-524
49. Witlin AG, Sibai BM (1998) Magnesium sulfate therapy in preeclampsia and eclampsia. Obstet Gynecol 92:883-889
50. Young WB, Siow HC, Silberstein SD (2004) Anticonvulsants in migraine. Curr Pain Headache Rep 8:244-250